Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients

European Journal of Endocrinology

Volumn 154, Issue 2, 2006, Pages 243-252

  Cohen, Ohad ^a   Ilany, Jacob ^a   Hoffman, Chen ^a   Olchovsky, David ^a   Dabhi, Sari ^a   Karasik, Avraham ^a   Goshen, Elinor ^a,b   Rotenberg, Galina ^a,b   Tzila Zwas, S ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IODINE 131; RECOMBINANT THYROTROPIN; THIONAMIDE DERIVATIVE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELIMINATION; DRUG SAFETY; ELDERLY CARE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; IODINE 131 UPTAKE TEST; LOW DRUG DOSE; MALE; NODULAR GOITER; NORMAL VALUE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; THYROIDITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; WEAKNESS;

AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THYROTROPIN; THYROXINE; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOTHYRONINE;

EID: 33644600612     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02094     Document Type: Article

References (19)

1. Hegedüs L, Bonnema SJ & Bennedbæk FN. Management of simple nodular goiter: current status and future perspectives. Endocrine Reviews 2003 24 102-132.
2. Wang C & Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinology and Metabolism Clinics of North America 1997 26 189-218.
3. Papi G, Pearce EN, Braverman LE, Betterle C & Roti E. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only. American Journal of Medicine 2005 118 349-361.
4. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865.
5. Bonnema SJ, Bennedbæk FN, Wiersinga WM & Hegedüs L. Management of the nontoxic multinodular goitre: a European questionnaire study. Clinical Endocrinology (Oxford) 2000 53 5-12.
6. Bonnema SJ, Bennedbæk FN, Ladenson PW & Hegedüs L. Management of the nontoxic multinodular goiter: a North American survey. Journal of Clinical Endocrinology and Metabolism 2002 87 112-117.
7. 131I therapy in patients with non-toxic multinodular goitre. European Journal of Endocrinology 1995 132 86-87.
8. Nygaard B, Hegedüs L, Gervil M, Hjalgrim H, Søe-Jensen P & Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. British Medical Journal 1993 307 828-832.
9. Hegedüs L, Hansen BM, Knudsen N & Hansen JM. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. British Medical Journal 1988 297 661-662.
10. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L & Hegedüs L. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. Journal of Clinical Endocrinology Metabolism 1999 84 3636-3641.
11. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C & Schlumberger M. Second primary malignancies in thyroid cancer patients. British Journal of Cancer 2003 89 1638-1644.
12. Huysmans DA, Nieuwlaat W, Erdtsieck J, Schellekens AP, Bus JW, Bravenboer B & Hermus AR. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodine uptake in nontoxic nodular goiter. Journal of Clinical Endocrinology and Metabolism 2000 85 3592-3596.
13. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH & Huysmans DA. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters. Journal of Clinical Endocrinology and Metabolism 2001 86 5330-5336.
14. Nieuwlaat WA, Hermus AR, Ross HA, Buijs WC, Edelbroek MA, Bus JW, Corstens FH & Huysmans DA. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone. Journal of Nuclear Medicine 2004 45 626-633.
15. Nieuwlaat WA, Huysmans DA, Van Den Bosch C, Sweep CG, Ross HA, Corstens FH & Hermus AR. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. Journal of Clinical Endocrinology and Metabolism 2003 88 3121-3129.
16. Duick DS & Baskin HJ. Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of non-toxic and toxic multinodular goiters. Endocrine Practice 2003 9 204-209.
17. Silva MNC, Rubió IGS, Romão R, Gebrin EMMS, Buchpiguel C, Tomimori E, Camargo R, Cardia MS & Medeiros-Neto G. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters. Clinical Endocrinology 2004 60 300-308.
18. Hegedüs L. Thyroid ultrasound. Endocrinology and Metabolism Clinics of North America 2001 2 339-360.
19. Albino CC, Mesa CO Jr, Olandoski M, Ueda CE, Woellner LC, Goedert CA, Souza AM & Graf H. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. Journal of Clinical Endocrinology and Metabolism 2005 90 2775-2780.